Paper40575641
Synergistic efficacy of phages along with vancomycin for eradication of vancomycin-resistant Enterococcus faecalis biofilms.
Sahu M and 3 others. World J Virol, 2025. Cited by 5 papers, by iCite.
Cite this record
ConductScience Library. Synergistic efficacy of phages along with vancomycin for eradication of vancomycin-resistant Enterococcus faecalis biofilms. Papers, record 40575641. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/40575641
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Synergistic efficacy of phages along with vancomycin for eradication of vancomycin-resistant Enterococcus faecalis biofilms.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References26
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 28720810 | Biofilm formation in enterococci: genotype-phenotype correlations and inhibition by vancomycin. | Sci Rep | 2017 | https://conductscience.org/library/papers/28720810 | PubMed |
| 2 | 29487585 | Identification and Characterization of T5-Like Bacteriophages Representing Two Novel Subgroups from Food Products. | Front Microbiol | 2018 | https://conductscience.org/library/papers/29487585 | PubMed |
| 3 | 31921055 | The Novel Enterococcus Phage vB_EfaS_HEf13 Has Broad Lytic Activity Against Clinical Isolates of Enterococcus faecalis. | Front Microbiol | 2019 | https://conductscience.org/library/papers/31921055 | PubMed |
| 4 | 29550930 | Piperacillin and ceftazidime produce the strongest synergistic phage-antibiotic effect in Pseudomonas aeruginosa. | Arch Virol | 2018 | https://conductscience.org/library/papers/29550930 | PubMed |
| 5 | 7699051 | Detection of glycopeptide resistance genotypes and identification to the species level of clinically relevant enterococci by PCR. | J Clin Microbiol | 1995 | https://conductscience.org/library/papers/7699051 | PubMed |
| 6 | 35633293 | Immunological and safety profile of bacteriophage therapy: A pre-clinical study. | J Appl Microbiol | 2022 | https://conductscience.org/library/papers/35633293 | PubMed |
| 7 | 37574030 | Sequential treatment effects on phage-antibiotic synergistic application against multi-drug-resistant Acinetobacter baumannii. | Int J Antimicrob Agents | 2023 | https://conductscience.org/library/papers/37574030 | PubMed |
| 8 | 31180166 | Enterococcal bacteraemia 'silent but deadly': a population-based cohort study. | Intern Med J | 2020 | https://conductscience.org/library/papers/31180166 | PubMed |
| 9 | 17726529 | Phage-Antibiotic Synergy (PAS): beta-lactam and quinolone antibiotics stimulate virulent phage growth. | PLoS One | 2007 | https://conductscience.org/library/papers/17726529 | PubMed |
| 10 | 22524448 | Synergistic phage-antibiotic combinations for the control of Escherichia coli biofilms in vitro. | FEMS Immunol Med Microbiol | 2012 | https://conductscience.org/library/papers/22524448 | PubMed |
| 11 | 30217844 | Phage-Antibiotic Synergy via Delayed Lysis. | Appl Environ Microbiol | 2018 | https://conductscience.org/library/papers/30217844 | PubMed |
| 12 | 27578757 | Molecular Basis for Lytic Bacteriophage Resistance in Enterococci. | mBio | 2016 | https://conductscience.org/library/papers/27578757 | PubMed |
| 13 | 35214158 | Phages against Pathogenic Bacterial Biofilms and Biofilm-Based Infections: A Review. | Pharmaceutics | 2022 | https://conductscience.org/library/papers/35214158 | PubMed |
| 14 | 28536572 | The Bacteriophage EF-P29 Efficiently Protects against Lethal Vancomycin-Resistant Enterococcus faecalis and Alleviates Gut Microbiota Imbalance in a Murine Bacteremia Model. | Front Microbiol | 2017 | https://conductscience.org/library/papers/28536572 | PubMed |
| 15 | 25662974 | Targeting Enterococcus faecalis biofilms with phage therapy. | Appl Environ Microbiol | 2015 | https://conductscience.org/library/papers/25662974 | PubMed |
| 16 | 24073680 | Enterococcus faecalis infective endocarditis: focus on clinical aspects. | Expert Rev Cardiovasc Ther | 2013 | https://conductscience.org/library/papers/24073680 | PubMed |
| 17 | 31349628 | Synergistic Action of Phage and Antibiotics: Parameters to Enhance the Killing Efficacy Against Mono and Dual-Species Biofilms. | Antibiotics (Basel) | 2019 | https://conductscience.org/library/papers/31349628 | PubMed |
| 18 | 23000091 | Phage-antibiotic synergism: a possible approach to combatting Pseudomonas aeruginosa. | Res Microbiol | 2013 | https://conductscience.org/library/papers/23000091 | PubMed |
| 19 | 22096488 | The age-related risk of co-existing meningitis in children with urinary tract infection. | PLoS One | 2011 | https://conductscience.org/library/papers/22096488 | PubMed |
| 20 | 29857065 | Enterococcus faecium produces membrane vesicles containing virulence factors and antimicrobial resistance related proteins. | J Proteomics | 2018 | https://conductscience.org/library/papers/29857065 | PubMed |
Cited by3
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 5 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42245503 | Phage-quinolone synergy: mechanisms, clinical strategies, and translational prospects. | Front Microbiol | 2026 | https://conductscience.org/library/papers/42245503 | PubMed |
| 42231337 | Antibacterial potential of five phages in controlling Enterococcus faecalis and Enterococcus faecium. | Virol J | 2026 | https://conductscience.org/library/papers/42231337 | PubMed |
| 41258817 | Novel lytic phages improve the antibiofilm activity of dalbavancin, daptomycin, and fosfomycin against vancomycin-resistant enterococci. | Microbiol Spectr | 2026 | https://conductscience.org/library/papers/41258817 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/40575641
GET https://conductscience.org/api/papers/v1/40575641/references?page=2